Literatur

Auf dieser Seite haben wir Ihnen wichtige Publikationen zum Thema CRS & HIPEC zusammengestellt.

Sie befinden sich hier:

Publikationen zum Thema Peritonealkarzinose, CRS & HIPEC

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 Patients.

Bakrin N, Cotte E, Golfier F, Gilly FN, Freyer G, Helm W, Glehen O, Bereder JM. 2011 Ann Surg Oncol

 

 

The treatment of advanced gastric cancer: current strategies and future perspectives.

Cervantes A, Roselló S, Roda D, Rodríguez-Braun E. 2008 Ann Oncol

 

Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results.

Chua TC, Robertson G, Liauw W, Farrell R, Yan TD, Morris DL. 2009 J Cancer Res Clin Oncol

 

Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.

Chua TC, Yan TD, Morris DL. 2009 J Surg Oncol

 

Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution.

Chua TC, Yan TD, Smigielski ME, Zhu KJ, Ng KM, Zhao J, Morris DL. 2009 Ann Surg Oncol

 

Peritoneal cystic mesothelioma: are surgery and HIPEC optimal first-line treatments?

Coccolini F, Manfredi R, Catena F, Vallicelli C, De Iaco PA, Martoni A, Lazzareschi D, Ansaloni L. 2012 Onkologie

 

Consensus statement on peritoneal mesothelioma.

Deraco M, Bartlett D, Kusamura S, Baratti D. 2008 J Surg Oncol

 

Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Elias D, Honoré C, Ciuchendéa R, Billard V, Raynard B, Lo Dico R, Dromain C, Duvillard P, Goéré D. 2008 Br J Surg

 

Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, Ferron G, Guilloit JM, Meeus P, Goéré D, Bonastre J. 2009m J Clin Oncol

 

Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer.

Glehen O, Schreiber V, Cotte E, Sayag-Beaujard AC, Osinsky D, Freyer G, François Y, Vignal J, Gilly FN. 2004 Arch Surg

 

Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin.

Hill AR, McQuellon RP, Russell GB, Shen P, Stewart JH 4th, Levine EA. 2011 Ann Surg Oncol

 

Peritoneal carcinomatosis from colorectal cancer

Jayne DG, Fook S, Loi C, Seow-Choen F. 2002 Br J Surg

 

Quality of life and nutritional assessment in peritoneal surface malignancy (PSM): recommendations for care.

McQuellon R, Gavazzi C, Piso P, Swain D, Levine E. 2008 J Surg Oncol

 

Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy.

Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG. 2005 Ann Surg

 

Treatment goals in ovarian cancer.

Ozols RF. 2005 Int J Gynecol Cancer

 

Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Schmidt U, Dahlke MH, Klempnauer J, Schlitt HJ, Piso P. 2005 Eur J Surg Oncol

 

Are there curative options to peritoneal carcinomatosis?

Sugarbaker PH. 2005 Ann Surg

 

Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.

Sugarbaker PH, Chang D. 1999 Ann Surg Oncol

 

Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy in the treatment of advanced epithelial ovarian cancer.

Tentes AA, Kakolyris S, Kyziridis D, Karamveri C. 2012 J Oncol

 

Quality of Life in Patients after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is It Worth the Risk?

Tsilimparis N, Bockelmann C, Raue W, Menenakos C, Perez S, Rau B, Hartmann J. 2012 Ann Surg Oncol

 

Toxicity and quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.

Tuttle TM, Zhang Y, Greeno E, Knutsen A. 2006 Ann Surg Oncol

 

Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.

Witkamp AJ, de Bree E, Van Goethem R, Zoetmulder FA. 2001 Cancer Treat Rev

 

Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma.

Yan TD, Black D, Savady R, Sugarbaker PH. 2006 J Clin Oncol

 

A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.

Yan TD, Black D, Savady R, Sugarbaker PH. 2007 Ann Surg Oncol

 

A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer.

Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, Morris DL. 2007 Ann Surg Oncol

 

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.

Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, Zhou YF, Xiong B, Yonemura Y, Li Y. 2011 Ann Surg Oncol

 

Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy.

Zani S, Papalezova K, Stinnett S, Tyler D, Hsu D, Blazer DG 3rd. 2012 J Surg Oncol

 

The long-term impact of hyperthermic intraperitoneal chemotherapy on survivors treated for peritoneal carcinomatosis: a cross-sectional study.

Zenasni F, Botella M, Elias D, Dauchy S, Boige V, Malka D, Ducreux M, Pignon JP, Goéré D, Pocard M. 2009 Support Care Cancer